1. Home
  2. FRST vs BCYC Comparison

FRST vs BCYC Comparison

Compare FRST & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primis Financial Corp.

FRST

Primis Financial Corp.

HOLD

Current Price

$15.23

Market Cap

355.0M

Sector

Finance

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.03

Market Cap

310.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRST
BCYC
Founded
2004
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.0M
310.7M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
FRST
BCYC
Price
$15.23
$4.03
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$13.90
AVG Volume (30 Days)
183.5K
292.3K
Earning Date
04-23-2026
04-30-2026
Dividend Yield
2.74%
N/A
EPS Growth
477.27
N/A
EPS
0.30
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$9.63
N/A
P/E Ratio
$50.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.55
$3.99
52 Week High
$15.48
$9.18

Technical Indicators

Market Signals
Indicator
FRST
BCYC
Relative Strength Index (RSI) 65.94 32.14
Support Level $13.71 N/A
Resistance Level N/A $4.75
Average True Range (ATR) 0.32 0.18
MACD 0.08 -0.03
Stochastic Oscillator 86.00 5.96

Price Performance

Historical Comparison
FRST
BCYC

About FRST Primis Financial Corp.

Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, It focuses on making loans secured mainly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in several industries, as well as loans to individuals for a variety of purposes. The company has two reportable segments: Primis Bank. This segment specializes in providing financing services to businesses in various industries along with consumer and residential loans to individuals. Primis Mortgage. This segment specializes in originating mortgages in a majority of the U.S. The revenue is from Primis Bank.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Share on Social Networks: